Rare diseases
Investigational molecules
Locations
Back to Portugal214 clinical trials in Braga, Portugal across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
PortugalStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
PortugalStudy on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis
PortugalStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
PortugalStudy of Zolbetuximab and CAPOX for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
PortugalStudy comparing semaglutide with insulin glargine in overweight adults with type 2 diabetes: effectiveness of combined treatment versus insulin alone
PortugalStudy on the Effectiveness and Safety of BAY 3283142 in Reducing Urine Albumin for Patients with Chronic Kidney Disease
PortugalStudy on the Effectiveness and Safety of Guselkumab for Patients with Fistulizing Perianal Crohn's Disease
PortugalPortugalStudy Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer
PortugalStudy on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
PortugalStudy on the Effectiveness and Safety of Fenebrutinib and Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative trials exploring treatments for multiple sclerosis, including chronic neuropathic pain management and new therapeutic approaches. Research also encompasses frontotemporal dementia and various types of migraines.
Studies focus on both symptom management and disease modification approaches.
Comprehensive research into various skin conditions, including plaque psoriasis, atopic dermatitis, and hidradenitis suppurativa. Clinical trials are evaluating new biological treatments and long-term management strategies.
Focus on developing targeted therapies for chronic skin conditions.
Investigation of novel treatments for autoimmune conditions, including studies on lupus nephritis and immune thrombocytopenia. Research aims to develop more effective therapeutic approaches.
Emphasis on innovative immunological interventions and targeted therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
